Analyst Ratings for Biohaven Pharma (BHVN)
BHVN Rating Summary
BHVN Price Target Summary
- Highest: $60.00 (BTIG)
- Lowest: $9.00 (Bernstein SocGen Group)
- Average: $23.47
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$23.47 (+136.6%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/6/2026 | Goldman Sachs | Corinne Johnson | New Coverage | Buy (N/A) |
23.00 (N/A) |
10.99 (9.92) |
-9.74% | Details |
| 1/21/2026 | RBC Capital » Updated 3/3/2026 |
Leonid Timashev | Upgrade | Outperform (Sector Perform) |
23.00 (22.00) |
12.68 (9.92) |
-21.77% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
